Evidence map›Paper›PMID 33414418›Full record

ReviewTranslational psychiatry2021

Towards in vivo imaging of functionally active 5-HT

Oriane Razakarivony, Adrian Newman-Tancredi, Luc Zimmer

Abstract readReview
In one paragraph

Review in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Antidepressant Augmentation of Antipsychotic Treatment in Schizophrenia: A Narrative Review.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. GMolecular pharmacology · 2023
    Article
  10. [European journal of nuclear medicine and molecular imaging · 2023
    Article
  11. Review
  12. MiR-4763-3p targetingAging and disease · 2022
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Oriane RazakarivonyUniversité de Lyon, Lyon Neuroscience Research Center, INSERM, CNRS, Lyon, France.
Adrian Newman-TancrediNeurolixis, Castres, France.
Luc ZimmerUniversité de Lyon, Lyon Neuroscience Research Center, INSERM, CNRS, Lyon, France. luc.zimmer@univ-lyon1.fr.ORCID 0000-0002-2805-7098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The serotonin 5-HT

Indexed as

SchizophreniaSerotonin 5-HT1 Receptor AgonistsAutoradiographyBrainHumansReceptor, Serotonin, 5-HT1ASerotoninReceptor, Serotonin, 5-HT1ASerotoninSerotonin 5-HT1 Receptor Agonists

Identifiers

PMID33414418
PMCPMC7791062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.